Avid Bioservices Inc (NASDAQ: CDMO) has benefited from exceptional positive changes in investment behavior: its shorter term price trend turned up, and its longer term price trend turned up.
Recent meaningful positive changes in fundamentals have benefitted Avid Bioservices Inc (NASDAQ: CDMO): significant quarterly earnings acceleration occurred, and the stock’s power rating rose above 70.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, CDMO is expected to be a modest Value Eraser.
Avid Bioservices has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Avid Bioservices has a very low Appreciation Score of 11 but a good Power Rating of 77, with the Low Neutral Value Trend Rating the result.
Recent Price Action
Avid Bioservices Inc (NASDAQ: CDMO) stock closed at $9.45 on 7/19/24 after a slight decline of -0.5%. This decline was accompanied by normal trading volume. The stock has risen 18.1% during the last week and has been exceptionally strong relative to the market over the last nine months.
Be the first to comment